Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market capitalization of $214 million, to Neutral from Underweight and adjusted the price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback